Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy

ClinicalTrials.gov ID: NCT02973100

Public ClinicalTrials.gov record NCT02973100. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 27, 2026, 12:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-Blind, Placebo-Controlled, 18-Week Trial of Investigational Dulaglutide Doses Versus Placebo in Patients With Type 2 Diabetes on Metformin Monotherapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy and safety of investigational doses of dulaglutide in participants with type 2 diabetes on metformin monotherapy.

Study identification

NCT ID
NCT02973100
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
318 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2016
Primary completion
Jul 14, 2017
Completion
Aug 13, 2017
Last update posted
Sep 22, 2019

2016 – 2017

United States locations

U.S. sites
38
U.S. states
21
U.S. cities
38
Facility City State ZIP Site status
Parexel Early Phase Unit at Glendale Glendale California 91206-4140 —
Marin Endocrine Associates Greenbrae California 94904 —
National Research Institute Huntington Park California 90255 —
National Research Institute Los Angeles California 90057 —
Catalina Research Institute, LLC Montclair California 91763 —
Artemis Institute for Clinical Research San Diego California 92103 —
Encompass Clinical Research Spring Valley Lake California 91978 —
University Clinical Investigators, Inc. Tustin California 92780 —
Infosphere Van Nuys California 91405 —
Diablo Clinical Research Walnut Creek California 94598 —
Chase Medical Research, LLC Waterbury Connecticut 06708 —
Axes Medical Research, LLC Cooper City Florida 33024 —
Clinical Research of South Florida Coral Gables Florida 33134 —
East Coast Institute For Research Jacksonville Florida 32204 —
New Horizon Research Center Miami Florida 33175 —
Suncoast Research Group, LLC Miami Lakes Florida 33135 —
Palm Harbor Medical Associates Palm Harbor Florida 34684 —
In-Quest Medical Research, LLC - Norcross Norcross Georgia 30071 —
East West Medical Institute Honolulu Hawaii 96814 —
Elite Cilnical Trials LLLP Blackfoot Idaho 83221 —
Solaris Clinical Research Meridian Idaho 83646 —
HSHS Medical Group Diabetes Research Springfield Illinois 62711 —
American Health Network Indianapolis Indiana 46254 —
Iderc, P.L.C. Des Moines Iowa 50314 —
Cotton O'Neil Diabetes and Endocrinology Center Topeka Kansas 66606 —
ActivMed Practices & Research, Inc Methuen Massachusetts 01844 —
StudyMetrix Research, LLC City of Saint Peters Missouri 63303 —
Manhattan Medical Research New York Mills New York 10016 —
High Point Clinical Trials Center High Point North Carolina 27265 —
Aventiv Research Columbus Ohio 43213 —
The Corvallis Clinic P.C. Corvallis Oregon 97330 —
Heritage Valley Medical Group, Inc. Beaver Pennsylvania 15009 —
New Phase Research & Development Knoxville Tennessee 37909 —
Dallas Diabetes Endocrine Center Dallas Texas 75230 —
Consano Clinical Research San Antonio Texas 78231 —
Clinpoint Trial, LLC Waxahachie Texas 75165 —
Chrysalis Clinical Research St. George Utah 84790 —
Rainier Clinical Research Center Renton Washington 98057 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02973100, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 22, 2019 · Synced Sep 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02973100 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →